Business
MedMira's Rapid HIV Test Approved for Sale in Nigeria
MedMira's Rapid HIV Test Approved for Sale in Nigeria
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\n\nDec. 10, 2009 (Canada NewsWire Group) -- HALIFAX, Dec. 10 /CNW/ -- MedMira Inc., (\"MedMira\") (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, announced today that its rapid HIV test has been approved by The National Agency for Food And Drug Administration and Control (NAFDAC) in Nigeria and has been issued with the registration number allowing the product to be marketed within the country.MedMira's strategic sales and marketing partner, Vitest AG (Vitest) has been working in the region for the past several months pursuing regulatory approval for MedMira's rapid HIV test and developing an appropriate business, marketing and sales strategy for this Country. Vitest is aiming to work with both the public and private sectors in order to provide them with our leading technology. Product orders for Nigeria are expected shortly with delivery to customers beginning in 2010.\"Our partnership strategy is proving to be a key vehicle to gain market entry in complex and challenging markets such as Africa. We worked directly with our partner Vitest, whose team members have spent a significant amount of time on the ground building key relationships and developing and in-depth understanding of the market needs and opportunities in Nigeria,\" said Hermes Chan, CEO, MedMira Inc. \"We are confident that our rapid HIV test will meet and exceed the expectations of Vitest's customers in Nigeria and quickly gain market traction becoming the test of choice.\"According to UNAIDS there were 2,600,000 million people in Nigeria infected with HIV. As a country with the third largest number of people living with HIV, the prevention and treatment of HIV is one of the Nigerian government's primary concerns. A National HIV/AIDS Strategic Framework to create education and testing programs to control the further spread of HIV is in place and as part of this strategy the government aims to provide HIV tests to 80 percent of the population. (www.avert.org)\"We are very excited to have gained regulatory approval in Nigeria and have moved a step closer to our goals of delivering a new high quality rapid HIV test to the Nigerian market,\" said Nicholas Dellaportas, Director of International Business Development and Sales, Vitest AG. \"This progress is the result of a great partnership between MedMira an...